Loading …

We develop predictive (AI) platforms to power precision biotech to produce potent antimicrobial therapies. Tailocins are nature's nanotech used by bacteria to outcompete their close kin. In development is our IP-protected, AI-powered platform that redesigns tailocins for their subsequent development into safe and effective precision drugs.
Annual Revenue$1M to $5M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.